InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Maris David, Director. Director active across 1 company, notably Amphastar Pharmaceuticals, Inc.. Aggregated, 2 disclosures have been published. History available since 7 June 2021. The latest transaction was disclosed on 7 June 2021 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
David Maris is a Director at Amphastar Pharmaceuticals, Inc. As a board member, he contributes to the governance of the company and the development of its strategy. His experience in the pharmaceutical sector allows him to provide important perspectives to the board.